As the world races to find an effective vaccine against the coronavirus, biotech companies like Germany's Biontech and Curevac are taking their research to South America. High local infection rates ensure ideal testing.
Facebook Messenger Web
A new study found that antibodies in patients vaccinated against COVID-19 were able to neutralize a version of the new variant. Researchers tested 10 mutations of the B117 variant, which was first identified in the UK.
The government in Rome has said it's planning legal action against pharmaceutical companies Pfizer and AstraZeneca over delays to the delivery of new coronavirus vaccines. The European Union has made a similar threat.
Vaccines are safe and save lives. The rapid development of COVID-19 vaccines has people asking questions. Here is an overview of the reactions and side effects you can expect.
The United Kingdom currently allows up to 12 weeks between the doses of the BioNTech-Pfizer vaccine — twice as long as the gap recommended by the vaccine's producers and the World Health Organization.
© 2021 Deutsche Welle |
Legal notice |
| Mobile version